Non-granulomatous panuveitis in a Colombian patient: attributable to Lyme disease? Reply

被引：0

|

作者：

Cuevas-Pelaez, Miguel ^{[1
]}

Correa-Garcia, Alexandra ^{[2
]}

Mario Lopez-Mahecha, Jorge ^{[2
]}

机构：

[1] Univ Antioquia, Medellin, Colombia

[2] Univ Antioquia, Programa Oftalmol, Medellin, Colombia

来源：

IATREIA | 2021年 / 34卷 / 01期

关键词：

D O I：

10.17533/udea.iatreia.88

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：86 / 88

页数：3

相关论文

共 21 条

[21] Results. - Sixteen patients were included (9 women and 7 men). They had recurrent anterior uveitis (n=10), recurrent scleritis (n=5) and intermediate uveitis. Opthalmological involvement was neither severe nor complicated. All patients combined, the annual relapse ratio (ARR) decreased from 1.8 (0.8-3.5) to 0.3 (0-1.6), (P=0.06). Colchicine was considered effective in three of 10 analyzable patients. In only one patient, treatment was stopped for adverse effects after six weeks. Conclusion. - In view of the interesting benefit-risk ratio of colchicine, it seems appropriate to focus on this molecule in non-granulomatous anterior uveitis and non-severe recurrent scleritis. © 2022 Socie acute accent te acute accent Nationale Franc , aise de Me acute accent decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.
Rogier, T.
Auvens, C.
Thibault, T.
Mouries-Martin, S.
Muller, G.
El Hssaini, N.
Turcu, A.
Besancenot, J. -f.
Bielefeld, P.
Devilliers, H.
REVUE DE MEDECINE INTERNE, 2022, 43 (11): : 640 - 644